Angi-NTG 2.6 for Pharmacists and Distributors

Product: Angi-NTG 2.6, Nitroglycerin Controlled Release Tablets 2.6 mg, along with approved excipients. Presentation: bottle of 30 tablets. Category: cardiac care. Regulatory status: Schedule H. The pack carries the statement that it is not to be sold by retail without the prescription of a Registered Medical Practitioner.

Dispense only against a valid prescription that identifies the prescriber with registration details, names the patient, and is legible and dated. Maintain the prescription register as required, retain records for the prescribed period, and keep sale bills issued in the normal course.

Do not accept requests for repeat supply beyond what the prescription permits, and refer the patient back to the prescriber where the prescription has lapsed. Where a patient asks for a substitution, direct the query to the prescriber rather than making the change at the counter, since anti anginal medicines are not freely interchangeable.

A short, structured counselling exchange prevents most avoidable problems with nitrates.

Nitroglycerin controlled release is used in the ongoing management of angina rather than for relief of an episode in progress. Assess baseline blood pressure and volume status, and consider situations where nitrates are best avoided, including severe aortic stenosis, hypertrophic obstructive cardiomyopathy, constrictive pericarditis, suspected right ventricular infarction, marked hypotension, raised intracranial pressure and severe anaemia.

Reconcile the full medicine list at every visit, with particular attention to phosphodiesterase type 5 inhibitors, riociguat, alpha blockers used in benign prostatic enlargement and other antihypertensives. Counsel patients that products obtained without a prescription also count.

Plan dosing so that a nitrate free interval is preserved, and review symptom frequency, postural symptoms and adherence at follow up. Advise patients not to discontinue abruptly, and to report any change in the pattern of angina without delay. Suspected adverse reactions can be reported through the Pharmacovigilance Programme of India.

Store Angi-NTG 2.6 in a cool, dry and dark place. In Indian retail conditions that means keeping cartons away from shop front display windows and direct sunlight, maintaining ventilation or air conditioning through the summer months, and protecting stock from monsoon dampness at floor level and along outer walls.

Keep cartons sealed until required, rotate stock on a first expiry first out basis, and check expiry dates at every stock review. Do not repack tablets or dispense loose tablets outside the original bottle, since the bottle carries the batch number, expiry date and storage instruction and is part of the product's protection.

Inspect incoming consignments for transit damage, moisture marks and seal integrity, and set any doubtful stock aside rather than placing it on the shelf. Record batch numbers at the point of sale so that any recall or query can be traced quickly.

EMK Omni Pharma, based in Mysuru, Karnataka, markets Angi-NTG 2.6 in India. The product is manufactured for the company at GMP certified contract manufacturing facilities, and the company handles marketing and distribution.

Pharmacies, hospitals, clinics, stockists and distributors who wish to enquire about availability, distribution rights or supply arrangements can get in touch through the contact page on the EMK Omni Pharma website, or on WhatsApp at +91 94487 74372. Please have your drug licence details and GST registration ready when you make an enquiry, as these are required for trade supply.

For product queries, batch related questions or documentation requests, the same channels can be used. Reports of suspected quality defects should be raised promptly with the batch number and pack details so that they can be investigated.

This article is for general information only and is not a substitute for advice from a registered medical practitioner.